A new report published in leading journal Diabetes Care indicates that one diabetes drug, despite being effective for treating diabetes pain, could lower the control over blood sugar levels.
Apparently, Duloxetine may have a negative affect on sugar control. Duloxetine is one of just two drugs that are prescribed for a phenomenon called diabetic peripheral neuropathic pain.
In order to produce the results, diabetes experts examined data from a variety of clinical trials investigating duloxetine. Long-term treatment with the drug indicated a strong rise in haemoglobin A1c.
The authors of the study reportedly commented that: “We hope these findings reported here will help (doctors) make informed decisions regarding the risks and benefits of duloxetine in patients seeking relief from painful diabetic neuropathy.”
Readers who take the drug are advised to consult their healthcare experts for further action.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…